[Mutants of Bacillus subtilis resistant to lysine analog S-2 aminoethyl-L-cysteine].
AECR mutants of Bacillus subtilis were obtained and analyzed. The mutants were characterized by derepression of aspartokinase II and diaminopimelate decarboxylase synthesis and the synthesis of the precursor of lysine--DAP. According to genetic mapping data, aec mutations are localized in some B. subtilis chromosomal regions; they are linked to the thr5, leuA8, lys21 markers.
Shevchenko
T N
TN
Timashova
E O
EO
Aleksieva
Z M
ZM
D001222:Aspartate Kinase / Q000037:antagonists & inhibitors / Q000378:metabolism; D001412:Bacillus subtilis / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D001426:Bacterial Proteins; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors / Q000378:metabolism; D002874:Chromosome Mapping; D003545:Cysteine / Q000031:analogs & derivatives* / Q000494:pharmacology; D003960:Diaminopimelic Acid / Q000378:metabolism; D004352:Drug Resistance, Microbial; D008040:Genetic Linkage; D009154:Mutation
D001426:Bacterial Proteins; C000204:S-2-aminoethyl cysteine; D003960:Diaminopimelic Acid; D001222:Aspartate Kinase; D002262:Carboxy-Lyases; C079912:LysA protein, Bacteria; C020031:diaminopimelic acid decarboxylase; D003545:Cysteine
Mutanty Bacillus subtilis, ustoĭchivye k analogu lizina S-2 aminoétil-L-tsisteinu.